advanced search

Welcome: Guest

log in

0 items in basket Total: £0
$0 / €0

View Basket

Global Protein Therapeutics Market Analysis

Publication Date August 2009
Publisher RNCOS
Product Type Report
Pages 155
ISBN Number not applicable
Product Code RCS00223
Buy this product or for assistance call +44 20 7060 7474
PDF £1,080.00$1796 | €1209
PRINT £1,325.00$2204 | €1483
CD-ROM £1,325.00$2204 | €1483
FAX Order above formats by FAX

Summary

The number of protein-based pharmaceuticals reaching the marketplace has exponentially increased over the past few years. As the global demand for innovative protein therapeutics is growing each year, a large number of investors are pouring money in the market. Moreover, new developments in manufacturing & production technology have led to significant advancements in protein manufacturing and production. The global protein therapeutics market registered a robust growth rate of over 14% in 2008.

According to our new research report Global Protein Therapeutics Market Analysis, the global protein therapeutics market is expected to grow at a CAGR of around 12% during 2010-2012. At present, the market is characterized by high cost treatments therapy and healthcare insurance which in turn helping the companies to generate more revenue.

Our report has found that the market is presently dominated by Monoclonal Antibodies. With double-digit growth projected for future, the segment is expected to bolster its dominant position. Insulin, Interferon Beta, G-CSF and coagulation factors are also exhibiting healthy growth rates. One of the biggest opportunity areas in the protein therapeutics market is biogenerics which are expected to create a multi-billion dollar market in future. Moreover, pharmaceutical contract research and manufacturing market is expected to grow at an unmatched rate on account of high cost factor in the market.

This report provides extensive information and rational analysis of the global protein therapeutics market. It includes detailed study of factors fueling growth in the protein therapeutics market to help clients gain deeper insight of the current and future trends in the global protein therapeutics market. The report also provides segment-wise market trends prevailing at regional level to provide an overview of developments taking place in these segments across the world.

Content

  • 1. Analyst View
  • 2. Global Proteins Therapeutic Market
    • 2.1 Market Analysis
      • 2.1.1 Market Size
      • 2.1.2 Proteins Therapeutic Market vs Pharmaceutical Market
      • 2.1.3 Market Segmentation
    • 2.2 Future Outlook (2010-2012)
  • 3. Industry Performance
    • 3.1 Monoclonal Antibodies (mAb)
      • 3.1.1 Market Size
      • 3.1.2 By Application
      • 3.1.3 Key Geographical Markets
      • 3.1.4 Key Players and Drugs
      • 3.1.5 Industry Analysis
      • 3.1.6 Future Outlook (2010-2012)
    • 3.2 Erythropoietin (EPO)
      • 3.2.1 Market Size
      • 3.2.2 By Application
      • 3.2.3 Key Geographical Markets
      • 3.2.4 Key Players and Drugs
      • 3.2.5 Industry Analysis
      • 3.2.6 Future Outlook (2010-2012)
    • 3.3 Insulin
      • 3.3.1 Market Size
      • 3.3.2 By Application
      • 3.3.3 Key Geographical Markets
      • 3.3.4 Key Players and Drugs
      • 3.3.5 Industry Analysis
      • 3.3.6 Future Outlook (2010-2012)
    • 3.4 Interferon (IFN)
      • 3.4.1 Market Size
      • 3.4.2 Key Geographical Markets
      • 3.4.3 Key Players and Drugs
      • 3.4.4 Industry Analysis
      • 3.4.5 Future Outlook (2010-2012)
    • 3.5 Human Growth Hormone (HGH)
      • 3.5.1 Market Size
      • 3.5.2 By Application
      • 3.5.3 Key Geographical Markets
      • 3.5.4 Key Players and Drugs
      • 3.5.5 Industry Analysis
      • 3.5.6 Future Outlook (2010-2012)
    • 3.6 Blood Clotting Factor
      • 3.6.1 Market Size
      • 3.6.2 Key Players and Drugs
      • 3.6.3 Industry Analysis
      • 3.6.4 Future Outlook (2010-2012)
    • 3.7 Follicle Stimulating Hormone (FSH)
      • 3.7.1 Market Size
      • 3.7.2 Key Players and Drugs
      • 3.7.3 Industry Analysis
      • 3.7.4 Future Outlook (2010-2012)
    • 3.8 Granulocyte Colony Stimulating Factor (G-CSF)
      • 3.8.1 Market Size
      • 3.8.2 Key Players and Drugs
      • 3.8.3 Industry Analysis
      • 3.8.4 Future Outlook (2010-2012)
  • 4. Emerging Market Trends
    • 4.1 Biogenerics
    • 4.2 Contract Research Outsourcing
    • 4.3 Contract Manufacturing
    • 4.4 Nanotechnology-enabled Drug Delivery Market
    • 4.5 Healthcare Insurance
    • 4.6 High Approval Rate
  • 5. Growth Inhibitors
    • 5.1 High R&D Cost
    • 5.2 High Price
    • 5.3 High Failure Rates in Phase-3 Clinical Trials
    • 5.4 Insurance Reimbursements
    • 5.5 Lack of Predictability in the Operating Environment
  • 6. Key Players
    • 6.1 Johnson & Johnson
    • 6.2 Biogen Idec Inc.
    • 6.3 Eli Lilly & Company
    • 6.4 Novo Nordisk A/S
    • 6.5 Sanofi-Aventis
    • 6.6 Roche Group
    • 6.7 Amgen Inc.
    • 6.8 Genentech, Inc.
    • 6.9 Merck Serono S.A
  • List of Figures:
    • Figure 2-1: Global - Proteins Therapeutic Market (Billion US$), 2007-2009
    • Figure 2-2: Global - Comparison of Proteins Therapeutic Market to Pharmaceutical Market (Billion US$), 2007 & 2008
    • Figure 2-3: Global - Proteins Therapeutic Market by Segment (%), 2008
    • Figure 2-4: Global - Forecast for Proteins Therapeutic Market (Billion US$), 2010-2012
    • Figure 2-5: Global - Forecast for Proteins Therapeutic Market by Segment (%), 2012
    • Figure 3-1: Global - Monoclonal Antibodies Market (Billion US$), 2007-2009
    • Figure 3-2: Global - Monoclonal Antibodies Market in Cancer Treatment (Billion US$), 2007-2009
    • Figure 3-3: Global - Monoclonal Antibodies Market in Rheumatoid Arthritis Treatment (Billion US$), 2007-2009
    • Figure 3-4: Global - Monoclonal Antibodies Market in Cardiovascular and Infectious Diseases Treatment (Billion US$), 2008
    • Figure 3-5: Global - Monoclonal Antibodies Market in Cardiovascular and Infectious Diseases Treatment (Billion US$), 2009
    • Figure 3-6: US - Monoclonal Antibodies Market (Billion US$), 2007-2009
    • Figure 3-7: US - Forecast for Monoclonal Antibodies Market (Billion US$), 2010-2012
    • Figure 3-8: Europe - Monoclonal Antibodies Market (Billion US$), 2007-2009
    • Figure 3-9: Europe - Forecast for Monoclonal Antibodies Market (Billion US$), 2010-2012
    • Figure 3-10: Europe - Forecast for Monoclonal Antibodies Market by Application (%), 2011
    • Figure 3-11: Japan - Monoclonal Antibodies Market (Billion JPY), 2007-2009
    • Figure 3-12: Japan - Forecast for Monoclonal Antibodies Market (Billion JPY), 2010-2012
    • Figure 3-13: Global - Share of Key Players in Monoclonal Antibodies Market (2008)
    • Figure 3-14: Global - Top Selling Monoclonal Antibodies (Billion US$)
    • Figure 3-15: Global - Forecast for Monoclonal Antibodies Market (Billion US$), 2010-2012
    • Figure 3-16: Global - Erythropoietin Market (Billion US$), 2006-2009
    • Figure 3-17: Global - First Generation Erythropoietin Market (Billion US$), 2006-2009
    • Figure 3-18: Global - First Generation Erythropoietin Alpha Market (Million US$), 2006-2009
    • Figure 3-19: Global - First Generation Erythropoietin Beta Market (Million US$), 2006-2009
    • Figure 3-20: Global - Second Generation Erythropoietin Market (Billion US$), 2006-2009
    • Figure 3-21: Global - Number of Patients on Dialysis (Million), 2007-2009
    • Figure 3-22: Global - Breakup of Patients on Dialysis by Region (%), 2008
    • Figure 3-23: Global - Number of New Cancer Cases (Million), 2008 & 2030
    • Figure 3-24: Global - Breakup of New Cancer Cases by Region (%), 2008
    • Figure 3-25: Europe - Erythropoietin & Untapped Erythropoietin Market for Chemotherapy (Million Euro), 2004
    • Figure 3-26: US - Share in Global Erythropoietin Market (%), 2008
    • Figure 3-27: Europe - Erythropoietin Market (Billion US$), 2007-2009
    • Figure 3-28: Europe - Forecast for Erythropoietin Market (Billion US$), 2010-2012
    • Figure 3-29: Europe - Erythropoietin Market in Renal Anemia Treatment (Million US$), 2007-2009
    • Figure 3-30: Europe - Erythropoietin Market in Oncology Treatment (Million US$), 2007-2009
    • Figure 3-31: Europe - First Generation Erythropoietin Patent Expiry by Major Country
    • Figure 3-32: Japan - Erythropoietin Market (Billion JPY), 2007-2009
    • Figure 3-33: Global - Forecast for Erythropoietin Market (Billion US$), 2010-2012
    • Figure 3-34: Europe - Forecast for Share of Oncology and Renal Anemia in Erythropoietin Market (%), 2016
    • Figure 3-35: Global - Insulin Market (Billion US$), 2006-2009
    • Figure 3-36: India - Number of Diabetic Patients (Million), 2008 & 2030
    • Figure 3-37: India - Insulin Market (Million US$), 2007-2009
    • Figure 3-38: India - Share of Key Players in Insulin Market
    • Figure 3-39: China - Insulin Market (Billion RMB), 2006-2009E
    • Figure 3-40: China - Share of Key Players in Insulin Market (Q3 2008)
    • Figure 3-41: US - Insulin Market (Billion US$), 2002-2006
    • Figure 3-42: US - Share of Key Players in Insulin Market (2008)
    • Figure 3-43: Russia - Insulin Market (Million US$), 2007-2009
    • Figure 3-44: Russia - Share of Key Players in Insulin Market (H1 2006)
    • Figure 3-45: Russia - Insulin Market by Channel of Sales (%), 2007
    • Figure 3-46: Japan - Insulin Market (Billion JPY), 2007-2009
    • Figure 3-47: Japan - Share of Key Players in Insulin Market (2008)
    • Figure 3-48: Germany - Share of Insulin in Genetically Manufactured Pharmaceuticals Market (2007)
    • Figure 3-49: Brazil - Insulin Market (Million BRL), 2007-2009
    • Figure 3-50: Brazil - Share of Key Players in Insulin Market (2007)
    • Figure 3-51: Global - Share of Key Players in Insulin Market (2008)
    • Figure 3-52: Share of Novo Nordisk in the Insulin Market of US, Europe and Japan (2008)
    • Figure 3-53: Global - Share of Brands in Insulin Market (2008)
    • Figure 3-54: Global - Number of Diabetic Patients (Million), 2007 & 2025
    • Figure 3-55: Global - Forecast for Insulin Market (Billion US$), 2010-2012
    • Figure 3-56: Global - Interferon Market (Billion US$), 2007-2009
    • Figure 3-57: Global - Share of Alpha and Beta in Interferon Market (2008)
    • Figure 3-58: Global - Interferon Alpha Market (Billion US$), 2007-2009
    • Figure 3-59: Global - Forecast for Hepatitis B Treatment Market (Billion US$), 2010-2015
    • Figure 3-60: Global - Hepatitis C Treatment Market (Billion US$), 2007-2009
    • Figure 3-61: Global - Forecast for Hepatitis C Treatment Market (Billion US$), 2010-2015
    • Figure 3-62: Global - Forecast for Share of Interferon in Hepatitis C Treatment Market (2015)
    • Figure 3-63: Global - Interferon Beta Market (Billion US$), 2007-2009
    • Figure 3-64: Global - Multiple Sclerosis Treatment Market (Billion US$), 2007-2009
    • Figure 3-65: US - Interferon Market (Billion US$)
    • Figure 3-66: Europe - Interferon Market (Million US$)
    • Figure 3-67: Japan - Interferon Market (Billion JPY), 2007-2009
    • Figure 3-68: Global - Forecast for Interferon Market (Billion US$), 2010-2012
    • Figure 3-69: Global - Human Growth Hormone Market (Billion US$), 2007-2009
    • Figure 3-70: US, Europe & Japan - Number of Patients with Pediatric Growth Hormone Deficiency ('000)
    • Figure 3-71: Global - Share of Growth Hormones in Treatment of Pediatric Short Stature (2006)
    • Figure 3-72: Global - Adult Growth Hormone Deficiency Market (Million US$), 2006
    • Figure 3-73: Global - Human Growth Hormone Market by Region (%), 2007
    • Figure 3-74: US - Human Growth Hormone Market (Billion US$), 2007-2009
    • Figure 3-75: Japan & Europe - Human Growth Hormone Market (Million US$), 2007
    • Figure 3-76: Global - Share of Key Players in Human Growth Hormone Market (2008)
    • Figure 3-77: Global - Forecast for Human Growth Hormone Market (Billion US$), 2010-2012
    • Figure 3-78: Global - Blood Clotting Factor Market (Billion US$), 2007-2009
    • Figure 3-79: Global - Share of Blood Clotting Factor Market by Segment (2008)
    • Figure 3-80: Global - Share of Key Players in Blood Clotting Factor Market (2008)
    • Figure 3-81: Global - Forecast for Blood Clotting Factor Market (Billion US$), 2010-2012
    • Figure 3-82: Global - Follicle Stimulating Hormone Market (Billion US$), 2007-2009
    • Figure 3-83: Global - Forecast for Follicle Stimulating Hormone Market (Billion US$), 2010-2012
    • Figure 3-84: Global - Granulocyte Colony Stimulating Factor Market (Billion US$), 2007-2009
    • Figure 3-85: US - Share in Global Granulocyte Colony Stimulating Factor Market
    • Figure 3-86: Global - Forecast for Granulocyte Colony Stimulating Factor Market (Billion US$), 2010-2012
    • Figure 4-1: Global - Sales of Biologics by Year of Patent Expiration (Billion US$), 2008-2015
    • Figure 4-2: Global - Biogenerics Market (Billion US$), 2007 & 2011
    • Figure 4-3: Global - Contract Research Outsourcing Market (Billion US$), 2008 & 2013
    • Figure 4-4: Global - Market for Pharmaceutical Contract Manufacturing (Billion US$), 2008-2012
    • Figure 4-5: Global - Nanotechnology-enabled Drug Delivery Market (Billion US$), 2007 & 2012
    • Figure 4-6: Global - Health Insurance Market (Billion US$), 2008-2012
    • Figure 4-7: Global - Approval Rate for Biopharmaceuticals and Conventional Pharmaceuticals
    • Figure 5-1: Global - Comparison of Annual Cost of Biotech Drugs to Traditional Drugs (US$), 2006
    • Figure 5-2: Global - Failure Rate in Phase-3 Clinical Trials of Biotech and Traditional Drugs
  • List of Tables:
    • Table 3-1: Global - Key Players and Drugs in Erythropoietin Alpha Market (Billion US$), 2008
    • Table 3-2: Global - Key Players and Drugs in Erythropoietin Beta Market (Billion US$), 2008
    • Table 3-3: Global - Key Players and Drugs in Darbepoetin Alpha Market (Billion US$), 2008
    • Table 3-4: China - Diabetic Patients in Age Group 20-79 Years ('000), 2007
    • Table 3-5: China - Forecast for Diabetic Patients in Age Group 20-79 Years ('000), 2025
    • Table 3-6: US - Diabetic Patients in Age Group 20-79 Years ('000), 2007
    • Table 3-7: US - Forecast for Diabetic Patients in Age Group 20-79 Years ('000), 2025
    • Table 3-8: Russia - Diabetic Patients in Age Group 20-79 Years ('000), 2007
    • Table 3-9: Russia - Forecast for Diabetic Patients in Age Group 20-79 Years ('000), 2025
    • Table 3-10: Japan - Diabetic Patients in Age Group 20-79 Years ('000), 2007
    • Table 3-11: Japan - Forecast for Diabetic Patients in Age Group 20-79 Years ('000), 2025
    • Table 3-12: Germany - Diabetic Patients in Age Group 20-79 Years ('000), 2007
    • Table 3-13: Germany - Forecast for Diabetic Patients in Age Group 20-79 Years ('000), 2025
    • Table 3-14: Brazil - Diabetic Patients in Age Group 20-79 Years ('000), 2007
    • Table 3-15: Brazil - Forecast for Diabetic Patients in Age Group 20-79 Years ('000), 2025
    • Table 3-16: Global - Key Players and Drugs in Interferon Alpha Market (Billion US$), 2008
    • Table 3-17: Global - Key Players and Drugs in Interferon Beta Market (Billion US$), 2008
    • Table 3-18: Global - Key Players and Drugs in Human Growth Hormone Market (Million US$), 2008
    • Table 3-19: Global - Key Players and Drugs in Blood Clotting Factor Market (Million US$), 2008
    • Table 3-20: Global - Key Players and Drugs in Follicle Stimulating Hormone Market (Million US$), 2008
    • Table 3-21: Global - Key Players and Drugs in Granulocyte Colony Stimulating Factor Market (Million US$), 2008
    • Table 4-1: US & Europe - Patent Expiry Dates for Recombinant Biologics
    • Table 4-2: US & EU - Forecast for Biogenerics Market by Segment (Million US$), 2010

back to top

Delivery Details

PDF:Delivered by email within 12 to 24 hours of placing the order (Mon-Fri)

PRINT/CD-ROM:Despatched within 2 to 4 working days.

Ask a question about this product

Need help finding the right product?

Related Products

Industry Events

Computing & Electronics

Customer Services

How To Buy
Formats & Delivery
Terms & Conditions
Account Options
Login/Register

call +44 (0) 20 7060 7474
or email us

Resources

Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Meet Us
Jobs
Contact Us
Categories and Subcategories

Post it

Del.icio.us
StumbleUpon
Reddit

logo: AddThis